Metataxonomic and Immunological Analysis of Feces from Children with or without Phelan-McDermid Syndrome
- PMID: 39458315
- PMCID: PMC11509408
- DOI: 10.3390/microorganisms12102006
Metataxonomic and Immunological Analysis of Feces from Children with or without Phelan-McDermid Syndrome
Abstract
Phelan-McDermid syndrome (PMS) is a neurodevelopmental disorder characterized by a developmental delay and autism spectrum disorder (ASD)-like behaviors. Emerging research suggests a link between gut microbiota and neuropsychiatric conditions, including PMS. This study aimed to investigate the fecal microbiota and immune profiles of children with PMS compared to healthy controls. Fecal samples were collected from children diagnosed with PMS and age-matched healthy controls. The bacterial composition was analyzed using 16S rRNA gene sequencing, while short-chain fatty acids (SCFAs) were quantified through gas chromatography. Immunological profiling was conducted using a multiplex cytokine assay. Significant differences were observed in the gut microbiota composition between PMS patients and controls, including a lower abundance of key bacterial genera such as Faecalibacterium and Agathobacter in PMS patients. SCFA levels were also reduced in PMS patients. Immunological analysis revealed higher levels of several pro-inflammatory cytokines in the PMS group, although these differences were not statistically significant. The findings indicate that children with PMS have distinct gut microbiota and SCFA profiles, which may contribute to the gastrointestinal and neurodevelopmental symptoms observed in this syndrome. These results suggest potential avenues for microbiota-targeted therapies in PMS.
Keywords: Phelan–McDermid syndrome; autism spectrum disorder; feces; immunoprofiling; microbiota; short-chain fatty acids.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures

Similar articles
-
Prospective study of autism phenomenology and the behavioural phenotype of Phelan-McDermid syndrome: comparison to fragile X syndrome, Down syndrome and idiopathic autism spectrum disorder.J Neurodev Disord. 2017 Nov 10;9(1):37. doi: 10.1186/s11689-017-9217-6. J Neurodev Disord. 2017. PMID: 29126394 Free PMC article.
-
Gait Abnormalities in Children with Phelan-McDermid Syndrome.J Child Neurol. 2023 Dec;38(13-14):665-671. doi: 10.1177/08830738231204395. Epub 2023 Oct 18. J Child Neurol. 2023. PMID: 37849292
-
Altered gut microbiota and short chain fatty acids in Chinese children with autism spectrum disorder.Sci Rep. 2019 Jan 22;9(1):287. doi: 10.1038/s41598-018-36430-z. Sci Rep. 2019. PMID: 30670726 Free PMC article.
-
Phelan-McDermid syndrome: a review of the literature and practice parameters for medical assessment and monitoring.J Neurodev Disord. 2014;6(1):39. doi: 10.1186/1866-1955-6-39. Epub 2014 Oct 8. J Neurodev Disord. 2014. PMID: 25784960 Free PMC article. Review.
-
Dissecting the 22q13 region to explore the genetic and phenotypic diversity of patients with Phelan-McDermid syndrome.Eur J Med Genet. 2023 May;66(5):104732. doi: 10.1016/j.ejmg.2023.104732. Epub 2023 Feb 21. Eur J Med Genet. 2023. PMID: 36822569 Review.
References
-
- Zablotsky B., Black L.I. Prevalence of children aged 3–17 Years with developmental disabilities, by urbanicity: United States, 2015–2018. Natl. Health Stat. Rep. 2020;139:1–7. - PubMed
-
- Arons M.H., Thynne C.J., Grabrucker A.M., Li D., Schoen M., Cheyne J.E., Boeckers T.M., Montgomery J.M., Garner C.C. Autism-associated mutations in ProSAP2/Shank3 impair synaptic transmission and neurexin-neuroligin-mediated transsynaptic signaling. J. Neurosci. 2012;32:14966–14978. doi: 10.1523/JNEUROSCI.2215-12.2012. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources